Organigram Global (OGI) Other Non-Current Liabilities (2019 - 2026)
Organigram Global (OGI) posted quarterly Other Non-Current Liabilities of $1.1 million for Q1 2026, down 76.2% on a QoQ basis from $4.5 million in Q4 2025.
Organigram Global (OGI) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Other Non-Current Liabilities for 6 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $4.5 million, changed N/A from the prior year.
- Other Non-Current Liabilities eased to $1.1 million in Q1 2026 per OGI's latest filing, from $4.5 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for OGI reached as high as $5.9 million in Q3 2025 and fell as low as $1.1 million in Q1 2026.
- A 3-year average of $3.5 million and a median of $3.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The largest YoY upside for Other Non-Current Liabilities was 137.73% in 2025 against a maximum downside of 137.73% in 2025.
- Year by year, Other Non-Current Liabilities stood at $2.5 million in 2024, then surged by 81.97% to $4.5 million in 2025, then tumbled by 76.2% to $1.1 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.1 million, $4.5 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Nov 30, 2021 | 8.22 Mn |
| Aug 31, 2021 | 10.19 Mn |
| May 31, 2021 | 9.20 Mn |
| Feb 28, 2021 | 4.67 Mn |
| Nov 30, 2020 | 4.72 Mn |
| Aug 31, 2020 | 2.85 Mn |
| May 31, 2020 | 2.20 Mn |
| Feb 29, 2020 | 2.32 Mn |
| Aug 31, 2019 | 844,892.90 |